blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0941132

EP0941132 - EXTRACORPOREAL BLOOD PROCESSING SYSTEM [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  21.07.2006
Database last updated on 02.11.2024
Most recent event   Tooltip21.07.2006Refusal of applicationpublished on 23.08.2006  [2006/34]
Applicant(s)For all designated states
Gambro, Inc.
10810 West Collins Avenue Lakewood
Colorado 80215 / US
[N/P]
Former [2000/39]For all designated states
Gambro, Inc.
10810 West Collins Avenue
Lakewood Colorado 80215 / US
Former [1999/37]For all designated states
COBE Laboratories, Inc.
1185 Oak Street
Lakewood Colorado 80215 / US
Inventor(s)01 / DOLOCEK, Victor, D.
6607 S. Atchison Way
Englewood, CO 80111 / US
02 / KAPPUS, John, J.
851 Lafayette Street
Denver, CO 80217 / US
03 / BRIERTON, Mark, Joseph
8184 Rossman Gulch Road
Morrison, CO 80465 / US
[1999/37]
Representative(s)Barlow, Roy James
J.A. KEMP & CO. 14, South Square Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [1999/37]Barlow, Roy James
J.A. KEMP & CO. 14, South Square Gray's Inn
London WC1R 5LX / GB
Application number, filing date98946000.110.09.1998
[1999/37]
WO1998US18809
Priority number, dateUSP 5858712.09.1997
USA09.09.1998
[1999/37]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9913926
Date:25.03.1999
Language:EN
[1999/12]
Type: A2 Application without search report 
No.:EP0941132
Date:15.09.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 25.03.1999 takes the place of the publication of the European patent application.
[1999/37]
Search report(s)International search report - published on:EP06.05.1999
ClassificationIPC:A61M1/36, B61L19/00, B61L19/06
[1999/37]
CPC:
A61M1/3639 (EP,US); A61M1/36224 (EP,US); A61M1/36225 (EP,US);
A61M1/3641 (EP,US); A61M2205/12 (EP)
Designated contracting statesDE,   ES,   FR,   GB,   IT [1999/37]
TitleGerman:SYSTEM ZUR EXTRAKORPORALEN BLUTBEHANDLUNG[1999/37]
English:EXTRACORPOREAL BLOOD PROCESSING SYSTEM[1999/37]
French:SYSTEME EXTRACORPOREL DE TRAITEMENT DU SANG[1999/37]
Entry into regional phase25.05.1999National basic fee paid 
25.05.1999Designation fee(s) paid 
25.05.1999Examination fee paid 
Examination procedure25.05.1999Examination requested  [1999/37]
18.03.2003Despatch of a communication from the examining division (Time limit: M07)
11.11.2003Reply to a communication from the examining division
27.04.2004Despatch of a communication from the examining division (Time limit: M06)
13.10.2004Reply to a communication from the examining division
27.10.2005Date of oral proceedings
18.11.2005Minutes of oral proceedings despatched
30.03.2006Despatch of communication that the application is refused, reason: substantive examination [2006/34]
09.04.2006Application refused, date of legal effect [2006/34]
Request for further processing for:11.11.2003Request for further processing filed
11.11.2003Full payment received (date of receipt of payment)
Request granted
27.11.2003Decision despatched
Fees paidRenewal fee
13.09.2000Renewal fee patent year 03
03.09.2001Renewal fee patent year 04
05.09.2002Renewal fee patent year 05
04.09.2003Renewal fee patent year 06
06.09.2004Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
30.09.200508   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]DE2823670  (FRAUNHOFER GES FORSCHUNG) [Y] 1-6,8-16,18-20,29,32,34,35,39,40 * page 7, line 1 - page 9, line 22 *;
 [A]US4625757  (DYKSTRA RAYMOND C [US]) [A] 23 * abstract * * column 2, line 6 - line 47 *;
 [A]GB2208714  (COBE LAB [US]) [A] 23 * abstract * * page 5, line 27 - page 7, line 14 * * page 9, line 17 - page 10, line 8 *;
 [A]EP0685721  (FRESENIUS AG [DE]);
 [A]WO9605494  (GAMBRO AB [SE], et al);
 [A]US5554115  (THOMAS V STANTON [US], et al) [A] 7,17,33 * abstract * * column 4, line 22 - line 65 * * column 5, line 11 - line 32 *;
 [XDY]WO9640322  (COBE LAB [US]) [XD] 30,31 * abstract * * page 45, line 17 - page 50, line 9 * * page 59, line 18 - page 60, line 6 * [Y] 1-6,8-16,18-20,29,32,34,35,39,40
by applicantUS4663125
 US4683053
 US5489413
 US5603902
 US5653887
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.